Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.

Both Toujeo and Lantus are once-daily formulations of insulin glargine, but the latter is designed to have a smoother release of active drug designed to reduce the risk of low blood sugar episodes ...

Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis ...

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

Invokana (canagliflozin) has potential interactions with alcohol, other medications, and some supplements. For example, Invokana can interact with lithium and other diabetes drugs. Invokana is ...

Hydrochlorothiazide has possible interactions with alcohol, other drugs, and certain supplements. Examples include other blood pressure drugs and nonsteroidal anti-inflammatory drugs (NSAIDs ...

Lisinopril is a generic prescription drug that’s used for managing high blood pressure and certain other heart problems. Lisinopril comes as a tablet that you swallow. Lisinopril is used to help ...